Single-Center 5-Year Observational Study of Thrice-Weekly Single-Strength Sulfamethoxazole–Trimethoprim as Adequate Prophylaxis for <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Heart Transplants

Background/Objectives: <i>Pneumocystis jirovecii</i> pneumonia is a significant contributor to morbidity and mortality in patients with solid organ transplants. Sulfamethoxazole–trimethoprim prophylaxis has greatly reduced the incidence of this deadly fungal infection. Traditional prophylactic dosin...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Kevin Lor, Catherine Le, Evan Kransdorf, Michelle Kittleson
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-02-01
Saila:	Transplantology
Gaiak:	<i>Pneumocystis</i> sulfamethoxazole–trimethoprim prophylaxis
Sarrera elektronikoa:	https://www.mdpi.com/2673-3943/6/1/3
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!